Cargando…
Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Telomeres are specialized nucleoprotein structures responsible for protecting chromosome ends in order to prevent the loss of genomic information. Telomere maintenance is required for achieving immortality by neoplastic cells. While most cancer cells rely on telomerase re-activation for linear chrom...
Autores principales: | Pompili, Luca, Leonetti, Carlo, Biroccio, Annamaria, Salvati, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741932/ https://www.ncbi.nlm.nih.gov/pubmed/29273061 http://dx.doi.org/10.1186/s13046-017-0657-3 |
Ejemplares similares
-
Patient-derived xenografts: a relevant preclinical model for drug development
por: Pompili, Luca, et al.
Publicado: (2016) -
Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
por: Porru, Manuela, et al.
Publicado: (2018) -
BRCA2 Deletion Induces Alternative Lengthening of Telomeres in Telomerase Positive Colon Cancer Cells
por: Pompili, Luca, et al.
Publicado: (2019) -
Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer
por: Porru, Manuela, et al.
Publicado: (2020) -
Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
por: Keritam, Omar, et al.
Publicado: (2022)